Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance.
about
Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clotCellular functions of tissue transglutaminaseSecretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrateOsteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1.Identification of a highly reactive substrate peptide for transglutaminase 6 and its use in detecting transglutaminase activity in the skin epidermisIdentification of transglutaminase reactive residues in human osteopontin and their role in polymerizationPlasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics.Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA.Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2Altered gene expression in highly purified enterocytes from patients with active coeliac disease.Identification of preferred substrate sequences for transglutaminase 1--development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin.Cell surface changes in the egg at fertilizationIdentification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles.Screening of substrate peptide sequences for tissue-type transglutaminase (TGase 2) using T7 phage cDNA library.Transglutaminase regulation of cell function.Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregationRapid interactome profiling by massive sequencingMathematical modeling of polyamine metabolism in mammals.Erythrocytic transglutaminase inhibition hemolysis at presentation of celiac disease.Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological statesCeliac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells.Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIATransglutaminase 2 inhibitors and their therapeutic role in disease states.Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?A comprehensive view of polyamine and histamine metabolism to the light of new technologies.Modification of heterotrimeric G-proteins in Swiss 3T3 cells stimulated with Pasteurella multocida toxin.Integrative proteomic profiling of protein activity and interactions using protein arrays.The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubulesExpression of Functional Recombinant Human Tissue Transglutaminase (TG2) Using the Bac-to-Bac Baculovirus Expression SystemTransglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis.Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues.Extracellular matrix modifications at fertilization: regulation of dityrosine crosslinking by transamidation.Variations in both TG1 and TG2 isozyme-specific in situ activities and protein expressions during mouse embryonic developmentTissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.Heparan sulfate and transglutaminase activity are required for the formation of covalently cross-linked hedgehog oligomers.The myofibroblast matrix: implications for tissue repair and fibrosis.Potential of transglutaminase 2 as a therapeutic target.
P2860
Q24619529-A38D4D44-A33F-4A1B-B74E-B1507A581546Q28260600-E2ADCF03-19EF-47FD-BC4D-962E2DAC30D0Q28478487-0405BFDA-3288-45A5-B73E-9EDB622EE43DQ28509843-E4A7BA8D-6E8B-4E9C-B107-17F548B608D9Q28591287-405E6B77-534E-45FD-9AEA-2645292E45AFQ28651507-CE939726-2E92-432D-AD19-8DADE4A899B8Q30997344-EA0DC18A-BFC0-45C7-9D15-758DCF1987F4Q33240965-70E89630-4DD9-480A-8612-51BE35DD5F52Q33262164-1E949243-702A-4F6D-B744-D691A245BA56Q33358934-D5BA8DE4-66EB-4BEB-B3F2-C5E9957304B2Q33380424-05DE3B70-E604-4A79-952C-79D976D792DCQ33491078-E26E7B06-544A-4B4E-A47C-5E1B5338DC8BQ33660874-74423021-3954-4A4B-91C6-1DD0E75ED7E7Q33701867-DE2BA778-DDA6-449E-86BD-217AA6389BC7Q33707936-CFBF4CF4-ABFD-48E9-ACB4-C850422FCA0BQ33814180-2DB3D720-BEFF-4251-98E0-3029BACF6335Q33871179-0F1C1EE6-620C-44FC-A607-7B11D526F81DQ33995976-741019C4-DAE4-4E9D-9356-D4630FBC50C3Q34354765-6C24E4DA-BABD-4D92-8E84-A61B1968D5B4Q34517980-5B93D404-9375-4127-A92E-7FEEFF4A3C8EQ35082964-28B7EA73-FFB3-459F-877D-90B38D9D8A3AQ35153828-3C39130A-B9FF-411A-A81B-84CE94D4C104Q35213282-0FB56326-3A8C-4DC4-82AF-7C970C10066BQ35989247-B73E8381-5147-4C7E-8430-8643D2F3DA72Q36186533-D13BD878-A0B7-4FE8-B944-0072E5A66742Q36346498-D72C7287-9E22-4144-B753-9F86B7FD4193Q36373622-1A668E54-724F-4DBB-8D48-D3AF54550B04Q36386888-CA0626F5-ECC1-4C1A-919F-073583603D4DQ36689128-C7D5C849-CDCD-46A5-BC01-C5FE2F858240Q36768195-50D01457-26E6-4EFC-94BE-D3B22B8BD148Q36837173-87FBFF01-2F66-4DD7-A9CE-BE5AAD76E97EQ37062778-7FD76361-AFCD-42B3-A87D-94EFD5F4679CQ37111745-E175B5FD-5638-483B-BA9F-1EF93021CD2FQ37186873-82169B3B-DC91-4F43-872E-7FF141577625Q37255857-0EAB327C-500C-4C53-83B8-D15C230C19ADQ37266151-7EB2B27B-FDD6-47AB-925B-72D16B3D1B2AQ37406648-E9626450-7A90-40FD-ABBA-7B591106D5ECQ37432054-221BBAA0-3E87-46E8-9BD7-30AB270C4BE9Q37733670-9DE45805-F1F7-4F60-BFCC-39E7E83B51F0Q37776508-FF6656DC-8760-4F50-8C91-EEC165A8079A
P2860
Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mammalian transglutaminases. I ...... physiopathological relevance.
@ast
Mammalian transglutaminases. I ...... physiopathological relevance.
@en
type
label
Mammalian transglutaminases. I ...... physiopathological relevance.
@ast
Mammalian transglutaminases. I ...... physiopathological relevance.
@en
prefLabel
Mammalian transglutaminases. I ...... physiopathological relevance.
@ast
Mammalian transglutaminases. I ...... physiopathological relevance.
@en
P2860
P1433
P1476
Mammalian transglutaminases. I ...... physiopathological relevance.
@en
P2093
Carla Esposito
Ivana Caputo
P2860
P304
P356
10.1111/J.1742-4658.2004.04476.X
P407
P577
2005-02-01T00:00:00Z